In 2019, highlighted studies discovered gut bacterial species associated with increased incidence of depression (93), and causal effects of butyrate-producing bacteria on metabolic traits confirmed by measuring glucose-stimulated insulin response and fecal short-chain fatty acids (94) and using bacterial species associated with obesity and poor lipidemia to improve cardiovascular risk models (89, 95). Here, INS is linked to depressive symptom measurement.